Josh and Jason are joined this week by <a href="https://infectiousdiseases.wustl.edu/faculty-staff/andrej-spec/">Andrej Spec</a> to further discuss the data coming out on remdesivir, specifically the recently released trial examining 5 days of therapy versus 10 days. They also hit on how we are all connected through health and the need for justice.

Links for this episode:

<ul>
<li><a href="https://www.elsevier.com/books/comprehensive-review-of-infectious-diseases/spec/978-0-323-56866-1">Comprehensive Review of Infectious Diseases (1st Edition)</a></li>
<li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2015301">Remdesivir for 5 or 10 Days in Patients with Severe Covid&#8211;19 | NEJM</a></li>
<li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext">Remdesivir in adults with severe COVID&#8211;19: a randomised, double-blind, placebo-controlled, multicentre trial | The Lancet</a></li>
</ul>

Have a question or comment? Drop us a line on our <a href="http://www.medi.io/connect">feedback form</a> or send <a href="https://twitter.com/JoshHerigon">Josh</a> or <a href="https://twitter.com/JasonGNewland">Jason</a> a tweet.

Listen on <a href="https://podcasts.apple.com/us/podcast/podcast-mediio/id815344580">Apple Podcasts</a><img src="https://feedpress.me/link/5648/13606284.gif" height="1" width="1"/>

003: A time for change

Weekly podcast hosted by Josh Herigon discussing the intersection of medicine, technology, social media, and design